Insulet
PODD
#1927
Rank
NZ$18.30 B
Marketcap
NZ$264.26
Share price
4.65%
Change (1 day)
-47.92%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

EPS for Insulet (PODD)

EPS in 2026 (TTM): NZ$7.41

According to Insulet's latest financial reports the company's current EPS (TTM) is NZ$7.42. In 2025 the company made an earnings per share (EPS) of NZ$6.04 a decrease over its 2024 EPS that were of NZ$10.31.

EPS history for Insulet from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$7.4122.75%
2025NZ$6.04-41.47%
2024NZ$10.31102.71%
2023NZ$5.094114.29%
2022NZ$0.12-69.57%
2021NZ$0.40109.09%
2020NZ$0.19-38.89%
2019NZ$0.31200%
2018NZ$0.10-113.04%
2017NZ-$0.79-9.8%
2016NZ-$0.88-60.47%
2015NZ-$2.2238.71%
2014NZ-$1.6012.05%
2013NZ-$1.43-23.15%
2012NZ-$1.86-12.2%
2011NZ-$2.12

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.07 103.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.22-16.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$6.19-16.51%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
NZ$48.68 556.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
NZ-$5.29-171.40%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
NZ$0.03449-99.53%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
NZ$4.14-44.19%๐Ÿ‡บ๐Ÿ‡ธ USA